logo
Plus   Neg
Share
Email

Carl Icahn Says He Won't Solicit Votes Against Cigna - Express Scripts Merger

Carl Icahn no longer plans to solicit votes from Cigna Corp. (CI) shareholders against the health insurer's deal to buy Express Scripts Holding Co. (ESRX) after two proxy-advisory firms recommended shareholders support the deal, the billionaire activist investor said in a statement Monday.

"In light of the ISS and Glass Lewis recommendations in favor of the Cigna/Express Scripts transaction and the significant stockholder overlap between the two companies, we have informed the SEC that we no longer intend to solicit proxies to vote against the transaction," Icahn said.

Last week, Carl Icahn urged Cigna shareholders to vote against the health insurer's acquisition of Express Scripts Holding Co., saying that Cigna was "dramatically overpaying for a highly challenged Express Scripts that was facing existential risks on several fronts.

In March, Cigna agreed to acquire Express Scripts in a cash and stock transaction valued at about $67 billion, including Cigna's assumption of about $15 billion in Express Scripts debt.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said that the current state of the COVID-19 pandemic in the U.S. is "really not good." The U.S. is the country worst-affected by the coronavirus and has recently seen a surge in coronavirus infections as lockdown restrictions are eased. Granules Pharmaceuticals, Inc. recalled twelve (12) lots of type 2 diabetes medication Metformin hydrochloride Extended-Release, in the form of oral film-coated tablets, for the potential presence of nitrosamine impurity, N-Nitrosodimethylamine (NDMA), above levels of the Acceptable Daily Intake Limit (ADI), the U.S. Food and Drug Administration or FDA said in a statement. Palantir Technologies Inc., the Silicon Valley big data analytics company that has handled U.S. government's certain sensitive projects, said it has confidentially filed documents with the Securities and Exchange Commission to go public. In a statement, the company said the proposed public listing of its Class A common stock is expected to take place after the SEC completes its review process.
Follow RTT